Palliative care in interstitial lung disease: living well

M Kreuter, E Bendstrup, AM Russell… - The Lancet …, 2017 - thelancet.com
Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

Telomere biology disorders

MLW Kam, TTT Nguyen, JYY Ngeow - NPJ genomic medicine, 2021 - nature.com
Telomere biology disorders (TBD) are a heterogeneous group of diseases arising from
germline mutations affecting genes involved in telomere maintenance. Telomeres are DNA …

Epidemiology and prognostic significance of cough in fibrotic interstitial lung disease

YH Khor, KA Johannson, V Marcoux… - American Journal of …, 2024 - atsjournals.org
Rationale: Cough is a key symptom in patients with fibrotic interstitial lung disease (ILD).
Objectives: This study evaluated the prevalence, longitudinal change, associations, and …

The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review

JYT Lee, G Tikellis, TJ Corte, NS Goh… - European …, 2020 - Eur Respiratory Soc
Background People with pulmonary fibrosis often experience a protracted time to diagnosis,
high symptom burden and limited disease information. This review aimed to identify the …

An examination and proposed definitions of family members' grief prior to the death of individuals with a life-limiting illness: A systematic review

J Singer, KE Roberts, E McLean, C Fadalla… - Palliative …, 2022 - journals.sagepub.com
Background: Research has extensively examined family members' grief prior to the death of
an individual with a life-limiting illness but several inconsistencies in its conceptualization of …

[HTML][HTML] Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey

CC Moor, MS Wijsenbeek, E Balestro… - ERJ Open …, 2019 - Eur Respiratory Soc
Introduction Pulmonary fibrosis (PF) and its most common form, idiopathic pulmonary
fibrosis (IPF), are chronic, progressive diseases resulting in increasing loss of lung function …

A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF)

C Bramhill, D Langan, H Mulryan, J Eustace-Cook… - Plos one, 2024 - journals.plos.org
Aims Patients diagnosed with idiopathic pulmonary fibrosis (IPF) have a high symptom
burden and numerous needs that remain largely unaddressed despite advances in …

[HTML][HTML] Idiopathic pulmonary fibrosis: a review of disease, pharmacological, and nonpharmacological strategies with a focus on symptoms, function, and health …

D Rozenberg, N Sitzer, S Porter, A Weiss… - Journal of Pain and …, 2020 - Elsevier
Despite several advances in treatment, idiopathic pulmonary fibrosis (IPF) remains a
progressive, symptomatic, and terminal disease in patients not suitable for lung …

Advance care planning needs in idiopathic pulmonary fibrosis: a qualitative study

M Kalluri, S Orenstein, N Archibald… - American Journal of …, 2022 - journals.sagepub.com
Introduction: Advance care planning is recommended in chronic respiratory diseases,
including Idiopathic Pulmonary Fibrosis. In practice, uptake remains low due to patient …

[HTML][HTML] What patients with idiopathic pulmonary fibrosis and caregivers want: filling the gaps with patient reported outcomes and experience measures

M Kalluri, F Luppi, G Ferrara - The American Journal of Medicine, 2020 - Elsevier
Idiopathic pulmonary fibrosis is a progressive disease, with a high mortality within the first 3-
5 years from diagnosis and a poor quality of life mainly because of the burden of symptoms …